Clinical Trials List
2022-09-01 - 2025-03-07
Phase II
Recruiting4
ICD-10K74.4
Secondary biliary cirrhosis
ICD-10K75.81
Nonalcoholic steatohepatitis (NASH)
ICD-10K76.0
Fatty (change of) liver, not elsewhere classified
ICD-10K76.89
Other specified diseases of liver
ICD-10R16.2
Hepatomegaly with splenomegaly, not elsewhere classified
ICD-9571.8
Other chronic nonalcoholic liver disease
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wan-Long Chuang Digestive System Department
- Ming-Lun Yeh Digestive System Department
- Jee-Fu Huang Digestive System Department
- Chia-Yen Dai Digestive System Department
- Kun Der Lin 無
- Chung-Feng Huang Digestive System Department
- 謝明彥 Digestive System Department
- 梁博程 Digestive System Department
- 黃駿逸 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiu Hung Chiu Digestive System Department
- 邱彥程 Digestive System Department
- 簡世杰 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shih-Jer Hsu Digestive System Department
- 蘇東弘 Digestive System Department
- 洪俊銘 Digestive System Department
- 曾岱宗 Digestive System Department
- Jia-Horng Kao Digestive System Department
- PEI-JER CHEN Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
672 participants
